Univar (NYSE:UNVR) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.91 by 9.89 percent. This is a 75.44 percent increase over earnings of $0.57 per share from the same period last year. The company reported quarterly sales of $3.02 billion which beat the analyst consensus estimate of $2.95 billion by 2.27 percent. This is a 26.02 percent increase over sales of $2.39 billion the same period last year.
China SXT Pharmaceuticals, Inc. Receives 180-Day Extension From Nasdaq To Meet Minimum Bid Price Rule
China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ:SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional
